Archive Newsletter

1. 10.16.18 -- ARM's State Of The Cell And Gene Therapy Sector
   10/16/2018
   10/16/18 Cell & Gene Newsletter
2. 10.10.18 -- Modular Facility Helps Scale Up Viral Vector Manufacturing
   10/10/2018
   10/10/18 Cell & Gene Newsletter
3. 10.09.18 -- ISCT's Miguel Forte On Unproven Cell And Gene Therapies
   10/9/2018
   10/09/18 Cell & Gene Newsletter
4. 10.02.18 -- Bridging The Knowledge Gap Around Cell And Gene Medicine
   10/2/2018
   10/02/18 Cell & Gene Newsletter
5. 09.25.18 -- CAR-T And The Voice Of The Patient
   9/25/2018
   09/25/18 Cell & Gene Newsletter
6. 09.21.18 -- Scalable Processes For Adenovirus Vector Production
   9/21/2018
   09/21/18 Cell & Gene Newsletter
7. 09.18.18 -- New Approaches To Market Access, Reimbursement For Gene & Cell Therapies
   9/18/2018
   09/18/18 Cell & Gene Newsletter
8. 09.11.18 -- Spark's Luxturna Gene Therapy: What Can We Learn From Its Development & Commercialization?
   9/11/2018
   09/11/18 Cell & Gene Newsletter
9. 09.04.18 -- Cell Sorting And Its Significance In Stem Cell Research
   9/4/2018
   09/04/18 Cell & Gene Newsletter
10. 08.28.18 -- How Are Cell and Gene Therapies Changing Drug Development Models?
    8/28/2018
    08/28/18 Cell & Gene Newsletter